Anesthetic neuroprotection: Antecedents and an appraisal of preclinical and clinical data quality

Current Pharmaceutical Design

Volumn 20, Issue 36, 2014, Pages 5751-5765

  Ishida, Kazuyoshi ^a   Berger, Miles ^b   Nadler, Jacob ^b   Warner, David S ^b  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anesthetic; Brain; Intravenous; Ischemia; Volatile

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; LIDOCAINE; PROPOFOL; NEUROPROTECTIVE AGENT;

ANESTHESIA MECHANISM; ARTICLE; BRAIN INJURY; CEREBRAL METABOLIC RATE; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; HEART SURGERY; HUMAN; NERVOUS SYSTEM PARAMETERS; NEUROPROTECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; SYSTEMATIC REVIEW (TOPIC); TRANSLATIONAL RESEARCH; ANIMAL; BRAIN INJURIES; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); DRUG SCREENING; METHODOLOGY; PROCEDURES;

ANESTHETICS; ANIMALS; BRAIN INJURIES; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; GUIDELINES AS TOPIC; HUMANS; NEUROPROTECTIVE AGENTS; RESEARCH DESIGN; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84925831343     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140204111701     Document Type: Article

References (150)

1. Terrell RC. The invention and development of enflurane, isoflurane, sevoflurane, and desflurane. Anesthesiology 2008; 108: 531-3.
2. Eger EI, 2nd, Sonner JM. Anaesthesia defined (gentlemen, this is no humbug). Best Pract Res Clin Anaesthesiol 2006; 20: 23-9.
3. Hudetz AG. General anesthesia and human brain connectivity. Brain Connect 2012; 2: 291-302.
4. Lee U, Ku S, Noh G, Baek S, Choi B, Mashour GA. Disruption of frontal-parietal communication by ketamine, propofol, and sevoflurane. Anesthesiology 2013; 118: 1264-1275.
5. Jordan D, Ilg R, Riedl V, et al. Simultaneous electroencephalographic and functional magnetic resonance imaging indicate impaired cortical top-down processing in association with anesthetic-induced unconsciousness. Anesthesiology 2013; 119: 1031-42.
6. Michenfelder JD. The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog. Anesthesiology 1974; 41: 231-6.
7. Newberg LA, Milde JH, Michenfelder JD. The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity. Anesthesiology 1983; 59: 23-8.
8. Michenfelder JD, Theye RA. Cerebral protection by thiopental during hypoxia. Anesthesiology 1973; 39: 510-7.
9. Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40: 2244-50.
10. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 2008; 39: 2824-9.
11. Taninishi H, Takeda Y, Kobayashi M, Sasaki T, Arai M, Morita K. Effect of nitrous oxide on neuronal damage and extracellular glutamate concentration as a function of mild, moderate, or severe ischemia in halothane-anesthetized gerbils. Anesthesiology 2008; 108: 1063-70.
12. Lasarzik I, Noppens RR, Wolf T, et al. Dose-dependent influence of sevoflurane anesthesia on neuronal survival and cognitive outcome after transient forebrain ischemia in Sprague-Dawley rats. Neurocrit Care 2011; 15: 577-84.
13. Warner DS, Ludwig PS, Pearlstein R, Brinkhous AD. Halothane reduces focal ischemic injury in the rat when brain temperature is controlled. Anesthesiology 1995; 82: 1237-45; discussion 27A.
14. Warner DS, McFarlane C, Todd MM, Ludwig P, McAllister AM. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Possible influence on thermoregulation. Anesthesiology 1993; 79: 985-92.
15. Sakai H, Sheng H, Yates RB, Ishida K, Pearlstein RD, Warner DS. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007; 106: 92-9; discussion 8-10.
16. Sheng SP, Lei B, James ML, et al. Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage. Anesthesiology 2012; 117: 1262-75.
17. Zhuang L, Yang T, Zhao H, et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012; 40: 1724-30.
18. Li L, Zuo Z. Isoflurane preconditioning improves short-term and long-term neurological outcome after focal brain ischemia in adult rats. Neuroscience 2009; 164: 497-506.
19. Kawaguchi M, Drummond JC, Cole DJ, Kelly PJ, Spurlock MP, Patel PM. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth Analg 2004; 98: 798-805.
20. Elsersy H, Sheng H, Lynch JR, Moldovan M, Pearlstein RD, Warner DS. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 2004; 100: 1160-6.
21. Pape M, Engelhard K, Eberspacher E, et al. The long-term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg 2006; 103: 173-9.
22. Warner DS, Deshpande JK, Wieloch T. The effect of isoflurane on neuronal necrosis following near-complete forebrain ischemia in the rat. Anesthesiology 1986; 64: 19-23.
23. Kudo M, Aono M, Lee Y, Massey G, Pearlstein RD, Warner DS. Effects of volatile anesthetics on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cultures. Anesthesiology 2001; 95: 756-65.
24. Harada H, Kelly PJ, Cole DJ, Drummond JC, Patel PM. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth Analg 1999; 89: 1442-7.
25. Sullivan BL, Leu D, Taylor DM, Fahlman CS, Bickler PE. Isoflurane prevents delayed cell death in an organotypic slice culture model of cerebral ischemia. Anesthesiology 2002; 96: 189-95.
26. Brosnan H, Bickler PE. Xenon neurotoxicity in rat hippocampal slice cultures is similar to isoflurane and sevoflurane. Anesthesiology 2013; 119: 335-44.
27. Nagels W, Demeyere R, Van Hemelrijck J, Vandenbussche E, Gijbels K, Vandermeersch E. Evaluation of the neuroprotective effects of S(+)-ketamine during open-heart surgery. Anesth Analg 2004; 98: 1595-603, table of contents.
28. Nussmeier NA, Arlund C, Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986; 64: 165-70.
29. Zaidan JR, Klochany A, Martin WM, Ziegler JS, Harless DM, Andrews RB. Effect of thiopental on neurologic outcome following coronary artery bypass grafting. Anesthesiology 1991; 74: 406-11.
30. Roach GW, Newman MF, Murkin JM, et al. Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology 1999; 90: 1255-64.
31. Mathew JP, Mackensen GB, Phillips-Bute B, et al. Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke 2009; 40: 880-7.
32. Messick JM, Jr., Casement B, Sharbrough FW, Milde LN, Michenfelder JD, Sundt TM, Jr. Correlation of regional cerebral blood flow (rCBF) with EEG changes during isoflurane anesthesia for carotid endarterectomy: critical rCBF. Anesthesiology 1987; 66: 344-9.
33. Batjer HH, Frankfurt AI, Purdy PD, Smith SS, Samson DS. Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms. J Neurosurg 1988; 68: 234-40.
34. Hoffman WE, Charbel FT, Edelman G, Ausman JI. Thiopental and desflurane treatment for brain protection. Neurosurgery 1998; 43: 1050-3.
35. Hindman BJ, Bayman EO, Pfisterer WK, Torner JC, Todd MM. No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. Anesthesiology 2010; 112: 86-101.
36. Lavine SD, Masri LS, Levy ML, Giannotta SL. Temporary occlusion of the middle cerebral artery in intracranial aneurysm surgery: time limitation and advantage of brain protection. J Neurosurg 1997; 87: 817-24.
37. Bilotta F, Gelb AW, Stazi E, Titi L, Paoloni FP, Rosa G. Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials. Br J Anaesth 2013; 110 Suppl 1: i113-i120.
38. Harris RJ, Symon L. Extracellular pH, potassium, and calcium activities in progressive ischaemia of rat cortex. J Cereb Blood Flow Metab 1984; 4: 178-86.
39. Rebeyka IM, Coles JG, Wilson GJ, et al. The effect of low-flow cardiopulmonary bypass on cerebral function: an experimental and clinical study. Ann Thorac Surg 1987; 43: 391-6.
40. Verhaegen M, Todd MM, Warner DS. Ischemic depolarization during halothane-nitrous oxide and isoflurane-nitrous oxide anesthesia. An examination of cerebral blood flow threshold and times to depolarization. Anesthesiology 1994; 81: 965-73.
41. Nellgård B, Mackensen GB, Pineda J, Wellons JC, 3rd, Pearlstein RD, Warner DS. Anesthetic effects on cerebral metabolic rate predict histologic outcome from near-complete forebrain ischemia in the rat. Anesthesiology 2000; 93: 431-6.
42. Busto R, Dietrich WD, Globus MY, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987; 7: 729-38.
43. Bart RD, Takaoka S, Pearlstein RD, Dexter F, Warner DS. Interactions between hypothermia and the latency to ischemic depolarization: Implications for neuroprotection. Anesthesiology 1998; 85: 1266-1273.
44. Warner DS, Takaoka S, Wu B, et al. Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology 1996; 84: 1475-84.
45. Schmid-Elsaesser R, Schroder M, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. EEG burst suppression is not necessary for maximum barbiturate protection in transient focal cerebral ischemia in the rat. J Neurol Sci 1999; 162: 14-9.
46. Samson D, Batjer HH, Bowman G, et al. A clinical study of the parameters and effects of temporary arterial occlusion in the management of intracranial aneurysms. Neurosurgery 1994; 34: 22-8; discussion 28-9.
47. Theye RA, Michenfelder JD. The effect of halothane on canine cerebral metabolism. Anesthesiology 1968; 29: 1113-8.
48. Hoff J, Smith A, Nielsen S, Larson P. Effects of barbiturate and halothane anesthesia on focal cerebral infarction in the dog. Surg Forum 1973; 24: 449-51.
49. Smith AL, Hoff JT, Nielsen SL, Larson CP. Barbiturate protection in acute focal cerebral ischemia. Stroke 1974; 5: 1-7.
50. Smith AL, Larson CP, Jr., Hoff JT. Effects of halothane on regional cerebral blood flow in experimental focal ischemia. Anesthesiology 1973; 39: 377-81.
51. Michenfelder JD, Theye RA. In vivo toxic effects of halothane on canine cerebral metabolic pathways. Am J Physiol 1975; 229: 1050-5.
52. Carlsson C, Harp JR, Siesjo BK. Metabolic changes in the cerebral cortex of the rat induced by intravenous pentothalsodium. Acta Anaesthesiol Scand Suppl 1975; 57: 1-17.
53. Astrup J, Sorensen PM, Sorensen HR. Inhibition of cerebral oxygen and glucose consumption in the dog by hypothermia, pentobarbital, and lidocaine. Anesthesiology 1981; 55: 263-8.
54. Todd MM, Drummond JC, U HS. The hemodynamic consequences of high-dose thiopental anesthesia. Anesth Analg 1985; 64: 681-7.
55. Mackensen GB, McDonagh DL, Warner DS. Perioperative hypothermia: use and therapeutic implications. J Neurotrauma 2009; 26: 342-58.
56. Michenfelder JD, Theye RA. The effects of anesthesia and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation. Anesthesiology 1970; 33: 430-9.
57. Smith DS, Rehncrona S, Westerberg E, Akesson B, Siesjo BK. Lipid peroxidation in brain tissue in vitro: antioxidant effects of barbiturates. Acta Physiol Scand 1979; 105: 527-9.
58. Mellion SA, Bennett KS, Ellsworth GL, et al. High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury. Pediatr Crit Care Med 2013; 14: 239-47.
59. Kim TK, Park IS. Comparative Study of Brain Protection Effect between Thiopental and Etomidate Using Bispectral Index during Temporary Arterial Occlusion. J Korean Neurosurg Soc 2011; 50: 497-502.
60. Facchini A, Magnoni S, Civelli V, Triulzi F, Nosotti M, Stocchetti N. Refractory Intracranial Hypertension in Posterior Reversible Encephalopathy Syndrome. Neurocrit Care 2013.
61. Yoon JR, Kim YS, Kim TK. Thiopental-induced burst suppression measured by the bispectral index is extended during propofol administration compared with sevoflurane. J Neurosurg Anesthesiol 2012; 24: 146-51.
62. Smith DS, Levy W, Maris M, Chance B. Reperfusion hyperoxia in brain after circulatory arrest in humans. Anesthesiology 1990; 73: 12-9.
63. Borjigin J, Lee U, Liu T, et al. Surge of neurophysiological coherence and connectivity in the dying brain. Proc Natl Acad Sci U S A 2013; 110: 14432-7.
64. Todd MM, Chadwick HS, Shapiro HM, Dunlop BJ, Marshall LF, Dueck R. The neurologic effects of thiopental therapy following experimental cardiac arrest in cats. Anesthesiology 1982; 57: 76-86.
65. Bleyaert AL, Nemoto EM, Safar P, et al. Thiopental amelioration of brain damage after global ischemia in monkeys. Anesthesiology 1978; 49: 390-8.
66. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. N Engl J Med 1986; 314: 397-403.
67. Goldberg RN, Moscoso P, Bauer CR, et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr 1986; 109: 851-6.
68. Ruth V, Virkola K, Paetau R, Raivio KO. Early high-dose phenobarbital treatment for prevention of hypoxic-ischemic brain damage in very low birth weight infants. J Pediatr 1988; 112: 81-6.
69. Gisvold SE, Safar P, Hendrickx HH, Rao G, Moossy J, Alexander H. Thiopental treatment after global brain ischemia in pigtailed monkeys. Anesthesiology 1984; 60: 88-96.
70. Longstreth WT, Jr., Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb LA. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology 2002; 59: 506-14.
71. Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res 2010; 1357: 142-51.
72. Jeon YT, Hwang JW, Lim YJ, Park SK, Park HP. Postischemic sevoflurane offers no additional neuroprotective benefit to preischemic dexmedetomidine. J Neurosurg Anesthesiol 2013; 25: 184-90.
73. Li H, Yin J, Li L, Deng J, Feng C, Zuo Z. Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiol Dis 2013; 54: 216-24.
74. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981; 12: 723-5.
75. Olsen TS, Larsen B, Herning M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke 1983; 14: 332-41.
76. Corkill G, Sivalingam S, Reitan JA, Gilroy BA, Helphrey MG. Dose dependency of the post-insult protective effect of pentobarbital in the canine experimental stroke model. Stroke 1978; 9: 10-2.
77. Moseley JI, Laurent JP, Molinari GF. Barbiturate attenuation of the clinical course and pathologic lesions in a primate stroke model. Neurology 1975; 25: 870-4.
78. Michenfelder JD, Milde JH, Sundt TM, Jr. Cerebral protection by barbiturate anesthesia. Use after middle cerebral artery occlusion in Java monkeys. Arch Neurol 1976; 33: 345-50.
79. Hoff JT, Smith AL, Hankinson HL, Nielsen SL. Barbiturate protection from cerebral infarction in primates. Stroke 1975; 6: 28-33.
80. Nehls DG, Todd MM, Spetzler RF, Drummond JC, Thompson RA, Johnson PC. A comparison of the cerebral protective effects of isoflurane and barbiturates during temporary focal ischemia in primates. Anesthesiology 1987; 66: 453-64.
81. Cole DJ, Cross LM, Drummond JC, Patel PM, Jacobsen WK. Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth 2001; 48: 807-14.
82. Drummond JC, Cole DJ, Patel PM, Reynolds LW. Focal cerebral ischemia during anesthesia with etomidate, isoflurane, or thiopental: a comparison of the extent of cerebral injury. Neurosurgery 1995; 37: 742-8; discussion 748-9.
83. Warner DS, Zhou JG, Ramani R, Todd MM. Reversible focal ischemia in the rat: effects of halothane, isoflurane, and methohexital anesthesia. J Cereb Blood Flow Metab 1991; 11: 794-802.
84. Belopavlovic M, Buchthal A, Beks JW. Barbiturates for cerebral aneurysm surgery. A review of preliminary results. Acta Neurochir (Wien) 1985; 76: 73-81.
85. McDermott MW, Durity FA, Borozny M, Mountain MA. Temporary vessel occlusion and barbiturate protection in cerebral aneurysm surgery. Neurosurgery 1989; 25: 54-61; discussion 61-2.
86. Todd MM, Hindman BJ, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005; 352: 135-45.
87. Engelhard K, Werner C, Reeker W, et al. Desflurane and isoflurane improve neurological outcome after incomplete cerebral ischaemia in rats. Br J Anaesth 1999; 83: 415-421.
88. Loepke AW, Priestley MA, Schultz SE, McCann J, Golden J, Kurth CD. Desflurane improves neurologic outcome after low-flow cardiopulmonary bypass in newborn pigs. Anesthesiology 2002; 97: 1521-7.
89. Wang J, Cottrell JE, Kass IS. Effects of desflurane and propofol on electrophysiological parameters during and recovery after hypoxia in rat hippocampal slice CA1 pyramidal cells. Neuroscience 2009; 160: 140-8.
90. Newman MF, Mathew JP, Grocott HP, et al. Central nervous system injury associated with cardiac surgery. Lancet 2006; 368: 694-703.
91. Stump DA. Embolic factors associated with cardiac surgery. Semin Cardiothorac Vasc Anesth 2005; 9: 151-2.
92. Groom RC, Quinn RD, Lennon P, et al. Detection and elimination of microemboli related to cardiopulmonary bypass. Circ Cardiovasc Qual Outcomes 2009; 2: 191-8.
93. Schreiner RS, Rider AR, Myers JW, Ji B, Kunselman AR, Myers JL, et al. Microemboli detection and classification by innovative ultrasound technology during simulated neonatal cardiopulmonary bypass at different flow rates, perfusion modes, and perfusate temperatures. ASAIO J 2008; 54: 316-24.
94. Liebold A, Khosravi A, Westphal B, et al. Effect of closed minimized cardiopulmonary bypass on cerebral tissue oxygenation and microembolization. J Thorac Cardiovasc Surg 2006; 131: 268-76.
95. Royse AG, Royse CF, Ajani AE, et al. Reduced neuropsychological dysfunction using epiaortic echocardiography and the exclusive Y graft. Ann Thorac Surg 2000; 69: 1431-8.
96. Neville MJ, Butterworth J, James RL, Hammon JW, Stump DA. Similar neurobehavioral outcome after valve or coronary artery operations despite differing carotid embolic counts. J Thorac Cardiovasc Surg 2001; 121: 125-36.
97. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann Thorac Surg 1999; 67: 1117-24.
98. Mitchell SJ, Merry AF, Frampton C, et al. Cerebral protection by lidocaine during cardiac operations: a follow-up study. Ann Thorac Surg 2009; 87: 820-5.
99. Hudetz JA, Iqbal Z, Gandhi SD, et al. Ketamine attenuates postoperative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand 2009; 53: 864-72.
100. Michenfelder JD. A valid demonstration of barbiturate-induced brain protection in man-at last. Anesthesiology 1986; 64: 140-2.
101. Nussmeier N, Fish K. Neuropsychological dysfunction after cardiopulmonary bypass: A comparison of two institutions. J Cardiothor Vasc Anesth 1991; 5: 584-8.
102. Newman MF, Murkin JM, Roach G, et al. Cerebral physiologic effects of burst suppression doses of propofol during nonpulsatile cardiopulmonary bypass. CNS Subgroup of McSPI. Anesth Analg 1995; 81: 452-7.
103. Brott T, Adams HP, Jr., Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-70.
104. Astrup J, Skovsted P, Gjerris F, Sorensen HR. Increase in extracellular potassium in the brain during circulatory arrest: effects of hypothermia, lidocaine, and thiopental. Anesthesiology 1981; 55: 256-62.
105. Shokunbi MT, Gelb AW, Wu XM, Miller DJ. Continuous lidocaine infusion and focal feline cerebral ischemia. Stroke 1990; 21: 107-11.
106. Shokunbi MT, Gelb AW, Peerless SJ, Mervart M, Floyd P. An evaluation of the effect of lidocaine in experimental focal cerebral ischemia. Stroke 1986; 17: 962-6.
107. Gelb AW, Steinberg GK, Lam AM, Manninen PH, Peerless SJ, Rassi-Neto A. The effects of a prophylactic bolus of lidocaine in focal cerebral ischaemia. Can J Anaesth 1988; 35: 489-93.
108. Warner DS, Godersky JC, Smith ML. Failure of pre-ischemic lidocaine administration to ameliorate global ischemic brain damage in the rat. Anesthesiology 1988; 68: 73-8.
109. Wang D, Wu X, Li J, Xiao F, Liu X, Meng M. The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg 2002; 95: 1134-41.
110. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346: 557-63.
111. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549-56.
112. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574-84.
113. Button KS, Ioannidis JP, Mokrysz C, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 2013; 14: 365-76.
114. Haley EC, Jr., Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 1997; 86: 467-74.
115. Kassell NF, Haley EC, Jr., Apperson-Hansen C, Alves WM. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. Journal of Neurosurgery 1996; 84: 221-8.
116. Sacchetti ML. Is it time to definitely abandon neuroprotection in acute ischemic stroke? Stroke 2008; 39: 1659-60.
117. van der Worp HB, de Haan P, Morrema E, Kalkman CJ. Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. J Neurol 2005; 252: 1108-14.
118. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006; 59: 467-77.
119. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30: 2752-8.
120. Macleod MR, Fisher M, O'Collins V, et al. Good laboratory practice: preventing introduction of bias at the bench. Stroke 2009; 40: e50-2.
121. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
122. Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007; 357: 562-71.
123. Savitz SI. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke. Exp Neurol 2007; 205: 20-5.
124. Philip M, Benatar M, Fisher M, Savitz SI. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke 2009; 40: 577-81.
125. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010; 7: e1000251.
126. Lee SY, Teoh PJ, Camm CF, Agha RA. Compliance of randomized controlled trials in trauma surgery with the CONSORT statement. J Trauma Acute Care Surg 2013; 75: 562-72.
127. Magin P, Victoire A, Zhen XM, et al. Under-reporting of socioeconomic status of patients in stroke trials: adherence to CONSORT principles. Stroke 2013; 44: 2920-2.
128. Latronico N, Metelli M, Turin M, Piva S, Rasulo FA, Minelli C. Quality of reporting of randomized controlled trials published in Intensive Care Medicine from 2001 to 2010. Intensive Care Med 2013; 39: 1386-95.
129. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276: 637-9.
130. Barker FG, 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS. In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery 2003; 52: 995-1007; discussion 1007-9.
131. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol 2001; 13: 83-92.
132. Samuels O, Webb A, Culler S, Martin K, Barrow D. Impact of a dedicated neurocritical care team in treating patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011; 14: 334-40.
133. Hocker J, Stapelfeldt C, Leiendecker J, et al. Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery: a double-blinded randomized controlled pilot study. Anesthesiology 2009; 110: 1068-76.
134. Sulemanji DS, Donmez A, Aldemir D, Sezgin A, Turkoglu S. Dexmedetomidine during coronary artery bypass grafting surgery: is it neuroprotective?-A preliminary study. Acta Anaesthesiol Scand 2007; 51: 1093-8.
135. Evans DE, Catron PW, McDermott JJ, Thomas LB, Kobrine AI, Flynn ET. Effect of lidocaine after experimental cerebral ischemia induced by air embolism. J Neurosurg 1989; 70: 97-102.
136. Himmelseher S, Pfenninger E, Georgieff M. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg 1996; 83: 505-12.
137. Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M. Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 1993; 79: 306-12.
138. Lei B, Cottrell JE, Kass IS. Neuroprotective effect of low-dose lidocaine in a rat model of transient focal cerebral ischemia. Anesthesiology 2001; 95: 445-51.
139. Reeker W, Werner C, Mollenberg O, Mielke L, Kochs E. Highdose S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia in rats. Can J Anaesth 2000; 47: 572-8.
140. Proescholdt M, Heimann A, Kempski O. Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Res 2001; 904: 245-51.
141. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology 1991; 75: 328-32.
142. Kuhmonen J, Pokorny J, Miettinen R, et al. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997; 87: 371-7.
143. Engelhard K, Werner C, Eberspacher E, et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96: 524-31, table of contents.
144. Rasool N, Faroqui M, Rubinstein EH. Lidocaine accelerates neuroelectrical recovery after incomplete global ischemia in rabbits. Stroke 1990; 21: 929-35.
145. Fujitani T, Adachi N, Miyazaki H, et al. Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: a microdialysis study in Mongolian gerbils. Neurosci Lett 1994; 179: 91-4.
146. Niiyama S, Tanaka E, Tsuji S, et al. Neuroprotective mechanisms of lidocaine against in vitro ischemic insult of the rat hippocampal CA1 pyramidal neurons. Neurosci Res 2005; 53: 271-8.
147. LoPachin RM, Gaughan CL, Lehning EJ, Weber ML, Taylor CP. Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons. Neuroscience 2001; 103: 971-83.
148. Schwartz RD, Yu X, Katzman MR, Hayden-Hixson DM, Perry JM. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J Neurosci 1995; 15: 529-39.
149. Jolkkonen J, Puurunen K, Koistinaho J, et al. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol 1999; 372: 31-6.
150. Lei B, Popp S, Capuano-Waters C, Cottrell JE, Kass IS. Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats. Neuroscience 2004; 125: 691-701.